NCT04109859 is a Phase 1 clinical trial of Saline in Jaundice, sponsored by Jiaolin Ning,MD.

Who is sponsoring NCT04109859?

NCT04109859 is sponsored by Jiaolin Ning,MD.

What drugs are being tested in NCT04109859?

Interventions in NCT04109859: Saline, Methylene Blue.

Is NCT04109859 still recruiting?

NCT04109859 is currently status unknown. Last updated 1 October 2019.

Last reviewed 2019-10-01 · How we verify

NCT04109859

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Methylene Blue on Perioperative Organ Function in Patients With Obstructive Jaundice

Status unknown Phase 1 Last updated 1 October 2019

What this trial tests

Phase 1 trial testing Saline in Jaundice in 64 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
21 January 2021

21 January 2021

Quick facts

Lead sponsor	Jiaolin Ning,MD
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	64
Start date	1 April 2019
Primary completion	21 January 2021
Estimated completion	21 January 2021
Sites	1 location across China

Drugs / interventions tested

Saline
Methylene Blue (METHYLENE BLUE) — full drug profile →

Conditions studied

Jaundice — all drugs for Jaundice →

Sponsor

Jiaolin Ning,MD

Who can join

Adults 18 to 70, any sex, with Jaundice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increased production of vasodilating substances such as NO plays an important role in the development of vasoplegic syndrome caused by obstructive jaundice.Methylene blue plays a role in raising blood pressure by inhibiting the vasodilator Nitric Oxide (NO)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Saline

Trials testing the same drug.

NCT06972407 — The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans · Phase 2 · not yet recruiting
NCT07375862 — Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostas · Phase 2 · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
NCT07064993 — Effects of Intraarticular Tramadol and Tramadol-Dexamethasone on Postoperative Pain After Knee Arthroscopy · Phase 4 · not yet recruiting

Other recruiting trials for Jaundice

Currently open trials in the same condition.

NCT06421844 — A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images · recruiting
NCT06173947 — SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04109859 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jiaolin Ning,MD
Last refreshed: 1 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04109859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing